Merck & Co. (MRK)
(Delayed Data from NYSE)
$103.46 USD
+0.98 (0.96%)
Updated Dec 1, 2023 04:00 PM ET
After-Market: $103.45 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/01/2024
Time: -- |
12/2023 | $0.15 | -173.89% |
Earnings Summary
For their last quarter, Merck & Co. (MRK) reported earnings of $2.13 per share, beating the Zacks Consensus Estimate of $1.94 per share. This reflects a positive earnings surprise of 9.79%. Look out for MRK's next earnings release expected on February 01, 2024. For the next earning release, we expect the company to report earnings of $0.15 per share, reflecting a year-over-year decrease of 90.74%.
Earnings History
Price & Consensus
Zacks News for MRK
Seagen's (SGEN) Combo Drug Expanded-Use sBLA Gets Priority Tag
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services